Pneumonic Plague
📧 Sign up to get email alerts when something new happens for Pneumonic Plague.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo.
Registry entry reports a new rapid antigen test for plague under evaluation in Ituri, Democratic Republic of the Congo, currently not yet re…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age [Phase 2]
Phase 2 clinical trial evaluating the immunogenicity, safety, and tolerability of the rF1V-1018 vaccine in adults 18-55 for pneumonic plague…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age [Phase 2]
Phase 2 trial evaluating immunogenicity, safety, and tolerability of the rF1V plague vaccine with CpG 1018 adjuvant versus rF1V vaccine alon…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinetics of JST-010 in Healthy Adults [Phase 1]
Phase 1 randomized, double-blind, dose-escalation and expansion study to assess the safety and pharmacokinetics of JST-010 in healthy adults…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Ciprofloxacin Versus an Aminoglycoside Followed by Ciprofloxacin for Bubonic Plague [Phase 3]
A Phase 3 trial comparing ciprofloxacin alone to an aminoglycoside followed by ciprofloxacin for bubonic and pneumonic plague has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V [Phase 1]
A Phase 1 trial evaluated the safety, tolerability, and immunogenicity of the recombinant plague vaccine rF1V for pneumonic plague preventiv…